Skip to main content
SupplementScience

Benefits of Pygeum

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • BPH symptom relief — Wilt et al. (2002) Cochrane review of 18 RCTs involving 1,562 men concluded that pygeum extract provided moderate improvement in overall urological symptoms and flow measures, with men taking pygeum more than twice as likely to report symptom improvement
  • Nocturia reduction — the Cochrane review found a 19% reduction in nighttime urination frequency, which is particularly meaningful for sleep quality in men with BPH
  • Anti-inflammatory mechanism — pentacyclic triterpenes (ursolic acid, oleanolic acid) inhibit 5-lipoxygenase and cyclooxygenase in prostate tissue, reducing prostaglandin and leukotriene-driven inflammation
  • Growth factor inhibition — pygeum extract inhibits fibroblast growth factors (FGF) and epidermal growth factor (EGF) in prostate tissue, which may slow prostatic hyperplasia progression
  • Secretory function — ferulic acid esters (n-docosanol) in pygeum improve prostatic secretory function and may reduce the frequency and volume of prostatic fluid abnormalities associated with BPH

What the Research Says

Pygeum has one of the strongest evidence bases among prostate supplements, anchored by the 2002 Cochrane review by Wilt et al. This systematic review analyzed 18 randomized controlled trials involving 1,562 men with BPH and concluded that pygeum bark extract (typically 100mg daily standardized to Tadenan specifications) provided statistically significant improvements in overall urological symptoms (65% of pygeum users reported improvement vs. 30% for placebo), nocturia (19% reduction), residual urine volume (24% reduction), and peak urine flow (23% increase). The extract is an approved pharmaceutical product in France (Tadenan), Germany, and Italy, where it is covered by national health insurance. Edgar et al. (2007) published a detailed analysis of pygeum's mechanism, confirming anti-inflammatory effects via 5-LOX inhibition and anti-proliferative effects via growth factor inhibition. Sustainability is a concern — Prunus africana is listed under CITES Appendix II due to overharvesting, and ethical sourcing should be verified.

Related Conditions

Prostate Health
Full Pygeum Guide

References

  1. (). Pygeum africanum for benign prostatic hyperplasia. Cochrane Database of Systematic Reviews. DOI
  2. (). A critical review of the pharmacology of the plant extract of Pygeum africanum in the treatment of LUTS. Neurourology and Urodynamics. DOI